Dietary saturated fat/cholesterol, but not unsaturated fat or starch, induces C-reactive protein associated early atherosclerosis and ectopic fat deposition in diabetic pigs
- Sietse J Koopmans1, 2Email author,
- Ruud Dekker1,
- Mariette T Ackermans3,
- Hans P Sauerwein4,
- Mireille J Serlie4,
- Heleen MM van Beusekom5,
- Mieke van den Heuvel5 and
- Wim J van der Giessen^5, 6
© Koopmans et al; licensee BioMed Central Ltd. 2011
Received: 18 April 2011
Accepted: 14 July 2011
Published: 14 July 2011
Diabetes is thought to accelerate cardiovascular disease depending on the type of diet. This study in diabetic subjects was performed to investigate the metabolic, inflammatory and cardiovascular effects of nutritional components typically present in a Western, Mediterranean or high glycaemic diet.
Streptozotocin-diabetic pigs (~45 kg) were fed for 10 weeks supplemental (40% of dietary energy) saturated fat/cholesterol (SFC), unsaturated fat (UF) or starch (S) in an eucaloric dietary intervention study.
Fasting plasma total, LDL and HDL cholesterol concentrations were 3-5 fold higher (p < 0.01) in SFC compared to UF and S pigs. Fasting plasma NEFA concentrations (mmol/L) were highest (p < 0.05) in SFC (1.09 ± 0.17), intermediate in UF (0.80 ± 0.14) and lowest in S pigs (0.58 ± 0.14) whereas plasma glucose (~13 mmol/L), triglyceride (~0.5 mmol/L) and insulin (~24 pmol/L) concentrations were comparable among SFC, UF and S pigs. The postprandial response area under the curves (AUC, 0-4 h) for glucose but not for insulin and triglyceride responses were intermediate in SFC (617 ± 144) and lowest (p < 0.05) in UF (378 ± 157) compared to S pigs (925 ± 139). Fasting hepatic glucose production, hepatic and peripheral insulin sensitivity and blood pressure were not different among pigs. C-reactive protein (CRP) concentrations (mg/L) were highest (p < 0.05) in SFC (25 ± 4), intermediate in S (21 ± 3) and lowest in UF pigs (14 ± 2). Liver weights, liver and muscle triglyceride concentrations, and the surface area of aorta fatty streaks were highest (p < 0.01) in SFC pigs. A positive correlation between postprandial plasma CRP and aorta fatty streaks was observed in SFC pigs (R2 = 0.95). Retroperitoneal fat depot weight (g) was intermediate in SFC (260 ± 72), lowest in S (135 ± 51) and highest (p < 0.05) in UF (571 ± 95) pigs.
Dietary saturated fat/cholesterol induces inflammation, atherosclerosis and ectopic fat deposition whereas an equally high dietary unsaturated fat load does not induce these abnormalities and shows beneficial effects on postprandial glycaemia in diabetic pigs.
KeywordsDiabetes Insulin Diet Unsaturated fat Saturated fat Cholesterol Inflammation C-reactive protein Atherosclerosis Pigs
The impact of an excess in dietary fats and carbohydrates on metabolic control, inflammation and cardiovascular disease has been studied and discussed in normal and (pre)diabetic subjects in both human [1–4] and animal studies [5–7]. In general, excessive dietary saturated fats and cholesterol increase the risk for the development of obesity, diabetes and cardiovascular diseases [6, 8–10] while dietary unsaturated fats are considered less harmful and do not impose an increased risk for the development of diabetes and cardiovascular diseases [1, 2, 6]. Dietary carbohydrates, in the form of starches, have a high glycaemic load and thereby worsen postprandial glucose, stimulate insulin secretion and de novo lipogenesis [11–14].
Most studies on the longer term (months) effects of dietary components have been carried out in normal or glucose intolerant individuals but limited information is available in diabetic subjects on metabolic control, inflammation, cardiovascular abnormalities and body composition [2, 12, 13, 15].
Longer term studies in diabetic humans are difficult to perform because adherence to the prescribed diets has proven to be extremely difficult  and because dietary effects on the pathophysiology of diabetes are usually small with respect to metabolic control, insulin sensitivity, inflammation and cardiovascular diseases [17, 18]. In addition, longer term studies are usually necessary to disclose any dietary effects on the pathophysiology of diabetes because part of the dietary effects are caused by changes in body composition. This can partly be overcome by studying animal models which are representative for the human situation, are highly homogenous and are kept under strictly standardized experimental conditions.
We have developed a pig model for diabetes mellitus type 2 in humans which is characterized by insulin resistance, hyperglycaemia as well as elevated plasma triglyceride and NEFA concentrations. The diabetic pigs are non-ketotic, anabolic and do not require insulin therapy . Pigs are like humans omnivores and as such, the functionality of the gastrointestinal tract is comparable between pigs and man and therefore the pig is an useful animal model for the study of dietary components [20, 21]. This makes the pig particular useful when the effect of diets is studied on diabetes accelerated dyslipidaemia and atherosclerosis [22–24]. Furthermore, coronary arteries of diabetic pigs have been shown to express low grade inflammation , a condition also described in humans with type 2 diabetes mellitus [13, 26, 27].
The aim of this dietary intervention study was to characterize and compare the medium/long-term (10 weeks) pathogenic effects of eucaloric diets 1) both high in supplemental fat, but differing in fat composition as reflected by mainly saturated fats and cholesterol (SFC) versus mainly unsaturated fats (UF) and 2) differing in supplemental fat (SFC or UF) versus supplemental carbohydrate (starch, S), on pre- and postprandial hyperglycaemia, lipidaemia and insulinaemia, on insulin sensitivity, blood pressure, circulating pro-inflammatory markers, retroperitoneal fat weight and on muscle, liver and aorta lipid deposits in diabetic pigs.
The performed research is in compliance with the ARRIVE guidelines on animal research . Experimental protocols describing the management, surgical procedures, and animal care were reviewed and approved by the ASG-Lelystad Animal Care and Use Committee (Lelystad, The Netherlands).
Animals, housing, diets and surgery
Domestic (Landrace × Yorkshire, D-line) pigs (barrows with an initial age and body weight of ~11 weeks and ~30 kg, respectively) were obtained (Bastiaanse, Espel, The Netherlands) and kept in specially designed metabolic pens (1.15 × 1.35 m) and adapted to the light/dark cycle (lights on at 05:00 h and off at 19:00 h) and a feeding schedule. Pigs were weighed weekly and the meal size was adjusted to the individual pig's weight. The pigs were fed 2.5-fold maintenance requirements for gross energy (GE) as established in a normal pig. This corresponded with a feeding level of 1045 kJ GE kg-1 BW0.75 (metabolic weight of the pigs) per day and is sufficient to ensure moderate growth in normal pigs .
Composition of the experimental diets
Saturated fat diet plus cholesterol
Unsaturated fat diet
Milk protein (caseinate)
Maltodextrin DE 19
Native pea starch
Total sugar and starch
Soy bean oil
Canola oil (rape oil/Lear)
Trisun 80, high oleic sunflower oil
Fiber: Fibrim 2000
Gross Energy (GE; MJ/kg)
Supplemental saturated fat plus cholesterol (SFC), unsaturated fat (UF), or starch (S) content was 40% of total dietary energy. SFC was derived from beef tallow (i.e. ~55% saturated, ~35% mono-unsaturated, and ~10% poly-unsaturated fatty acids) plus 1% cholesterol, UF was derived from sunflower and rape oil (i.e. ~65% poly-unsaturated, ~25% mono-unsaturated, and 10% saturated fatty acids) and S was derived from pea starch, representing components of a Western, Mediterranean or high glycaemic diet, respectively.
Meal tolerance test and blood pressure
During the one-week recovery period after surgery, the pigs were habituated to the blood sampling and experimental procedures. The carotid artery catheter was used for blood sampling and registration of blood pressure. During the blood sampling procedure, the catheters were flushed with physiological saline and sealed off with physiological saline containing 5 IU heparin per mL. From experience we know that this sampling procedure does not affect plasma NEFA concentrations.
Blood was sampled repeatedly before, during and after the morning meal (-15, 0, 30, 60, 120, 240, 360, and 480 minutes from the start of feeding). Per sampling time point, approximately 5 ml blood was sampled. The responses of insulin, glucose and triglycerides were assessed. In addition, the pre-and post-prandial levels of C-reactive protein (CRP), haptoglobin, IL-6 and TNF-α were determined on samples taken 15 minutes before and 180 minutes after the start of feeding. Subsequent to the meal tolerance test, the blood pressure and heart rate were determined five hours post-prandially on a Digital Electromanometer, Type 330 (Hugo Sachs Elektronik KG, March-Hugstetten, Germany).
Hyperinsulinaemic euglycaemic clamp and 6,6-2H2-glucose infusion
The jugular vein catheter was used for the infusion of fluids and the carotid artery catheter was used for blood sampling during the hyperinsulinaemic clamp study. Preceding the insulin clamp, overnight fasting blood samples were collected for determining the concentrations of fructosamine, glucagon, cortisol, NEFA, total cholesterol, LDL and HDL cholesterol and background glucose enrichment.
After baseline samples, a prime (4.8 mg/kg)-continuous (0.08 mg.kg-1.min-1) infusion of 6,6-2H2-glucose was administered for 150 min. After an equilibration time, blood samples were taken at 110, 120, 130, 140 and 150 min for determination of glucose, 6,6-2H2-glucose enrichment (to estimate fasting hepatic glucose production) and insulin. Subsequently, insulin was infused (prime (34 mU/kg)-continuous (2 mU.kg-1.min-1)) for 6 hours. A variable infusion of a 33% D-glucose solution was started to maintain plasma glucose at euglycaemia (~5 mmol/L). Steady state calculations were carried out during the last 40 minutes of the clamp (t = 320, 330, 340, 350 and 360 min) and the coefficients of variation for the insulin and glucose concentrations, and for the infusion rate of glucose were determined. During the last 3 hours of the insulin clamp, a prime (4.8 mg/kg)-continuous (0.08 mg.kg-1.min-1) infusion of 6,6-2H2-glucose was superimposed to estimate 1) insulin stimulated whole body glucose uptake (rate of disappearance = Rd) and 2) insulin-inhibited hepatic glucose production, as described before . For this purpose blood samples were taken at t 320, 330, 340, 350 and 360 min of the clamp.
Infusates: Insulin (Actrapid MC, porcine monocomponent, Novo, Copenhagen, Denmark), 6,6-2H2-glucose (Cambridge Isotope Laboratories, Inc, MA, USA) and D-glucose (Merck, Darmstadt, Germany) were prepared as sterile solutions and passed through a 0.22 μm Millipore filter into sterile containers before use. Insulin was diluted in a saline solution containing pig plasma (final plasma concentration was 3%) in order to avoid sticking of insulin to the plastic containers and tubings. 6,6-2H2-glucose was dissolved in a saline solution and D-glucose was dissolved in aqua dest.
Plasma, urine and tissue collection and analyses
Blood samples collected in heparinised (150 USP. U. Lithium Heparin, 10 mL Venoject, Terumo, Leuven, Belgium) or EDTA (ethylenediaminetetraacetic acid, (0.47 mol/L EDTA, 10 mL Venoject, Terumo, Leuven, Belgium) tubes were immediately chilled at 0°C on water with ice, and centrifuged at 4°C for 10 minutes at 3000 rpm. Plasma aliquots were stored at -80°C for later analyses. Urine was quantitatively collected per 24 hours in buckets containing 0.5 grams Halamid-d (sodium-p-toluenesulfonchloramide, Akzo Nobel Chemicals, Amersfoort, The Netherlands) to prevent microbial breakdown of glucose. Urine samples were stored at -20°C for later glucose analyses. Muscle (m. iliopsoasis) and liver were snap-frozen in liquid nitrogen and stored at -80°C. Abdominal aorta was fixed in a 4% paraformaldehyde solution.
Plasma samples for determination of 6,6-2H2-glucose enrichment were analyzed as described previously . In short, glucose was extracted from plasma, derivatised, and injected into a gas chromatograph/mass spectrometer system (HP 6890 series GC system and 5973 Mass Selective Detector, Palo Alto, CA, USA). Separation was achieved on a J&W scientific DB 17 capillary column (30 m × 0.25 mm × 0.25 μm; Agilent Technologies Nederland BV, Amstelveen, The Netherlands). Isotopic enrichment was calculated as tracer-to- tracee ratio after subtracting the isotopic enrichment of a background plasma sample. An aliquot of the 6,6-2H2-glucose infusate was analyzed for the isotope concentration to calculate the actual infusion rate for each infusion experiment.
Plasma glucose was analyzed with the Glucose liquiUV mono kit (Human, Wiesbaden, Germany), plasma non-esterified fatty acids were analyzed with the WAKO kit (Neuss, Germany) and plasma triglycerides with a kit from Human (Wiesbaden, Germany). Total, LDL and HDL cholesterol concentrations in plasma were determined with liquicolor kits (Human, Wiesbaden, Germany) and VLDL cholesterol was calculated as total cholesterol minus LDL and HDL cholesterol. Plasma insulin concentration was measured using a Delfia assay (test kit by Perkin Elmer Life Sciences Trust by Wallac Oy, Turku, Finland). This specific pig insulin assay was validated using pig insulin standards, as indicated before . Plasma glucagon was measured with a kit from Euro-Diagnostica (Arnhem, The Netherlands), plasma cortisol with the Count-A-Count Cortisol kit (DPC, Los Angeles, USA) and fructosamine by a kit from Spinreact (Sant Esteve De Bas, Spain). Plasma C-reactive protein (CRP), interleukin-6 (IL-6) and tumor necrosis factor alpha (TNF-α) were analyzed with kits (CRP-hs, Human, Wiesbaden, Germany; Haptoglobin, Instruchemie, Delfzijl, The Netherlands; SW Interleukin 6, IBL, Hamburg, Germany and SW TNF-alpha Elisa Kit, Biosource Int, Camarillo, USA), respectively.
Ketones (acetoacetic acid) were determined in fresh urine by a reagent strip test (Ketostix, Bayer Diagnostics, Mijdrecht, The Netherlands).
Triglyceride concentrations in muscle and liver samples were determined with the same kit as used for the plasma samples, after saponification with an alkalin alcohol solution as previously described .
Aortic fatty streaks, as a marker of early atherosclerosis [22, 24], (AHA class 2 lesion ), were quantified with use of Sudan IV fat stain in sections of the abdominal aorta ranging from the bifurcation of the renal arteries to the bifurcation of the iliac arteries. The stained aortas were then photographed and analyzed with a microscopy image analysis system (Clemex technologies Inc., Quebec, Canada) as ratio of stained area to total area.
Results are expressed as means ± SEM and the criterion of statistical significance was set at p < 0.05. The data were subjected to the analysis of variance procedure (ANOVA) (for repeated measurements when applicable) followed by the unpaired or paired student's t-test of Genstat 5  for determination of differences between or within the three dietary groups, respectively.
Food intake, urinary glucose excretion, final body weights and tissue data of diabetic pigs fed saturated fat/cholesterol or unsaturated fat or starch enriched diets
Saturated fat plus cholesterol diet
Unsaturated fat diet
Factual average food intake (MJ/day)
23.9 ± 1.3
25.0 ± 2.0
27.7 ± 0.9
Average urinary glucose excretion (MJ/day)
8.5 ± 1.0A
9.1 ± 1.1A
15.8 ± 2.1B
Final body weight (kg)
41 ± 3
45 ± 5
48 ± 7
Liver weight (kg)
1.47 ± 0.08A
1.12 ± 0.03B
1.11 ± 0.03B
Liver triglyceride concentration (g/kg)
49 ± 11A
27 ± 1B
21 ± 3B
Muscle triglyceride concentration (g/kg)
21 ± 4A
13 ± 3AB
8 ± 1B
Retroperitoneal fat weight (g)
260 ± 72AB
571 ± 95A
135 ± 51B
Surface area aorta fatty steaks (%)
17.9 ± 4.4A
0.03 ± 0.02B
0.14 ± 0.07B
Fasting hepatic glucose production, insulin-stimulated whole body glucose uptake, insulin-inhibited hepatic glucose production and plasma concentrations of metabolites and insulin in diabetic pigs fed saturated fat/cholesterol or unsaturated fat or starch enriched diets
Saturated fat plus cholesterol diet
Unsaturated fat diet
Fasting plasma fructosamine (μmol/L)
449 ± 25
494 ± 62
558 ± 103
Fasting plasma glucose (mmol/L)
12.4 ± 0.4
14.4 ± 0.7
12.7 ± 1.6
Fasting plasma insulin (pmol/L)
23 ± 7
26 ± 7
22 ± 4
Fasting hepatic glucose production (mg.kg -1 .min -1 )
7.4 ± 0.8
6.4 ± 0.5
8.2 ± 2.0
Clamp plasma glucose (steady state, mmol/L)
5.7 ± 0.2
5.4 ± 0.2
5.4 ± 0.2
Clamp plasma insulin (steady state, pmol/L)
320 ± 27
409 ± 33
327 ± 33
Insulin-stimulated whole body glucose uptake (mg.kg -1 .min -1 )
10.0 ± 2.3
9.5 ± 2.1
10.8 ± 2.8
Insulin-inhibited hepatic glucose production
(mg.kg -1 .min -1 )
1.8 ± 0.2
1.2 ± 0.3
1.8 ± 0.1
Fasting plasma concentrations of lipid metabolites, hormones and inflammatory markers in diabetic pigs fed saturated fat/cholesterol or unsaturated fat or starch enriched diets
Saturated fat plus cholesterol diet
Unsaturated fat diet
1.09 ± 0.17A
0.80 ± 0.14AB
0.58 ± 0.14B
0.58 ± 0.17
0.51 ± 0.05
0.43 ± 0.11
Total cholesterol (mmol/L)
9.9 ± 1.2A
2.0 ± 0.1 B
1.7 ± 0.2 B
HDL cholesterol (mmol/L)
2.1 ± 0.2A
0.4 ± 0.0 B
0.5 ± 0.0 B
LDL cholesterol (mmol/L)
3.3 ± 0.3A
1.3 ± 0.1 B
1.1 ± 0.1 B
VLDL cholesterol (mmol/L)
4.5 ± 0.8A
0.2 ± 0.1 B
0.1 ± 0.0 B
Ratio HDL/LDL cholesterol
0.64 ± 0.08
0.35 ± 0.05
0.46 ± 0.03
Ratio HDL/total cholesterol
0.21 ± 0.01A
0.23 ± 0.02A
0.29 ± 0.01 B
131 ± 25
114 ± 35
83 ± 10
334 ± 44
284 ± 69
262 ± 50
251 ± 132
394 ± 100
236 ± 52
2224 ± 1102
818 ± 664
459 ± 270
610 ± 289
394 ± 248
384 ± 135
Atherosclerosis and blood pressure
Blood pressure and heart rate in diabetic pigs fed saturated fat/cholesterol or unsaturated fat or starch enriched diets
Saturated fat plus cholesterol diet
Unsaturated fat diet
Mean arterial pressure
113 ± 14
96 ± 5
96 ± 4
Systolic pressure (mmHg)
139 ± 18
117 ± 5
116 ± 5
Diastolic pressure (mmHg)
97 ± 13
78 ± 5
78 ± 4
Heart rate (beats per minute)
109 ± 10
92 ± 21
109 ± 22
Pigs on dietary SFC showed a more atherogenic plasma profile with higher plasma NEFA concentrations, higher liver weights and liver triglyceride concentrations, and increased aorta fatty streak area compared to pigs on dietary UF and S. The postprandial glucose, but not insulin and triglyceride responses were intermediate in SFC pigs, lowest in UF pigs and highest in S pigs, whereas hepatic and whole body insulin sensitivities for glucose metabolism were not significantly affected by the diets. This indicates that the postprandial glucose intolerance of S pigs compared to SFC and UF pigs is caused by an increased systemic influx of dietary glucose after starch digestion and not by insulin resistance. The mechanisms behind the relative postprandial glucose intolerance in SFC pigs compared to UF pigs are unknown. However, several non-significant factors may contribute to the difference in postprandial glucose tolerance. Fasting and insulin-inhibited hepatic glucose production during the clamp were elevated by 16% (p = NS) and 50% (p = NS) and early (30 min) postprandial insulin secretion was 2-fold reduced (p = NS) in SFC pigs compared to UF pigs. For the latter, it has been suggested that the degree of saturation of fatty acids may have a negative influence on insulin release by beta-cells in vitro . Taken together, these factors may add-up and act in concert to both impair non-insulin-dependent and insulin-dependent glucose tolerance in SFC pigs compared to UF pigs.
With respect to body composition, SFC pigs showed increased muscle, liver and aorta fat deposits and a reduced amount of retroperitoneal fat. The latter non-ectopic depot of adipose tissue was largest in UF pigs, indicating that body composition is most favourably affected by the UF diet compared to the SFC diet in this non-obese diabetic pig model. The UF diet is mainly stored in adipose tissue and to a lesser extent in organs and the vascular system. By contrast, the S pigs showed the lowest muscle and liver fat deposits and a low amount of retroperitoneal fat. This indicates that energy storage in the form of fat is low from dietary S, both in adipose and non-adipose tissue. The baseline markers of systemic inflammation tended to be higher in SFC pigs, but only baseline and postprandial CRP concentrations reached levels of statistical significance. A strong correlation was observed between postprandial plasma CRP and aorta fatty streak area (R2 = 0.95, p < 0.001), suggesting that postprandial CRP is a biomarker for atherosclerosis in this diabetic pig model. This is one of the few pieces of evidence that the inflammatory marker CRP is secondary to the atheromatous process itself.
Taken together, these main findings indicate that dietary saturated fat/cholesterol induces CRP associated early atherosclerosis and ectopic fat deposition whereas eucaloric unsaturated fat or starch do not induce these abnormalities and unsaturated fat shows beneficial effects on postprandial glycaemia in diabetic pigs.
After a 10-week intervention study, dietary composition had no significant effect on insulin sensitivity in diabetic pigs. This is in line with a 2-week intervention study in type 2 diabetic patients . In non-diabetic rodents however, it is widely accepted that long-term feeding of dietary saturated fats induces insulin resistance whereas unsaturated fats increase insulin sensitivity . This discrepancy may be caused by the fact that insulin resistance is already a prominent feature of diabetic humans  and pigs  and any modest dietary effect on insulin sensitivity does not come to expression in insulin resistant individuals. For example, both liver  and skeletal muscle  triglyceride concentrations have been shown to affect insulin sensitivity but in the present study, the diet-induced 2-fold variation in liver and skeletal muscle triglyceride concentrations is insufficient to further modulate insulin resistance in diabetic pigs.
Fasting plasma concentrations of the acute phase protein CRP were higher in diabetic pigs which were fed the SFC diet compared to the UF diet but not to the S diet. This underlines the anti-inflammatory effect of dietary UF [37, 38]. The pro-inflammatory effect of a diet rich in saturated fats and cholesterol has been shown before in non-diabetic humans [8, 10] and in non-diabetic pigs [39, 40]. In our study, postprandial plasma CRP, but not haptoglobin, IL-6 or TNF-α, positively correlated with the severity of beginning atherosclerosis. It seems therefore that postprandial CRP concentrations, which were increased 2-fold compared to fasting concentrations, react strongly to vascular damage and/or atherosclerosis . Indeed, CRP has been proposed as a putative clinical biomarker for atherosclerosis [42, 43] serving a possible protective role in the atherogenic process . In diabetic pigs which were fed a diet rich in UF, no increase in postprandial CRP was observed. This corresponds with the absence of atherosclerosis in these diabetic pigs. The beneficial mechanism of action of UF, but not SFC, may be related to the affinity to bind to the nuclear peroxisome proliferator-activated receptor (PPAR), the same pathway which is activated by the anti-diabetic drug thiazolidinedione (TZD) [27, 45–47]. Therefore, dietary UF can be regarded as a therapeutic agent to prevent some of the abnormalities of type 2 diabetes.
Diabetic pig model
Fasting plasma insulin (~25 pmol/L), glucose (~13 mmol/L) and triglyceride (~0.5 mmol/L) concentrations and a positive energy balance (body weight gain of ~1.5 kg/week) without the occurrence of ketosis indicated a mild form of diabetes in the pigs. In a previous paper we argued that the present insulin resistant pig model resembled type 2 diabetes . In addition to these observations, we now showed that, after streptozotocin treatment, the residual beta-cells of the pancreas were able to increase insulin secretion ~5-7 fold upon a meal-challenge. This indicates that a substantial endogenous insulin secretion capacity is still present in this diabetic pig model.
When comparing dietary SFC, UF and S, dietary SFC induces CRP-associated early atherosclerosis and ectopic fat deposition whereas isoenergetic UF shows beneficial effects on postprandial glycaemia, inflammation and body composition in diabetic pigs.
area under the curve
non-esterified fatty acids
peroxisome proliferator-activated receptor
polyunsaturated fatty acids
saturated fat with cholesterol
Acknowledgements and Funding
This study is dedicated to our beloved friend and colleague WJG, deceased.
This study was supported by the Ministry of Agriculture, Nature and Food Quality of The Netherlands. We thank Z. Mroz for the excellent surgical assistance.
- Din JN, Newby DE, Flapan AD: Omega 3 fatty acids and cardiovascular disease-fishing for a natural treatment. Br Med J. 2004, 328: 30-35. 10.1136/bmj.328.7430.30.View Article
- Esposito K, Marfella R, Ciotola M, Di Palo C, Giugliano F, Giugliano G, D'Armiento M, D'Andrea F, Giugliano D: Effect of a Mediterranean-style diet on endothelial dysfunction and markers of vascular inflammation in the metabolic syndrome. J Am Med Assoc. 2004, 292: 1440-1446. 10.1001/jama.292.12.1440.View Article
- Esposito K, Giugliano D: Diet and inflammation: a link to metabolic and cardiovascular diseases. Eur Heart J. 2006, 27: 15-20.View ArticlePubMed
- Rallidis LS, Paschos G, Liakos GK, Velissaridou AH, Anastasiadis G, Zampelas A: Dietary α-linolenic acid decreases C-reactive protein, serum amyloid A and interleukin-6 in dyslipidaemic patients. Atherosclerosis. 2003, 167: 237-242. 10.1016/S0021-9150(02)00427-6.View ArticlePubMed
- Jönsson T, Ahrén B, Pacini G, Sundler F, Wierup N, Steen S, Sjöberg T, Ugander M, Göransson L, Lindeberg S: A Paleolithic diet confers higher insulin sensitivity, lower C-reactive protein and lower blood pressure than a cereal-based diet in domestic pigs. BMC Nutrition & Metabolism. 2006, 3: 39.View Article
- Buettner R, Parhofer KG, Woenckhaus M, Wrede CE, Kunz-Schughart LA, Schölmerich J, Bollheimer LC: Defining high-fat-diet rat models: metabolic and molecular effects of different fat types. J Mol Endo. 2006, 36: 485-501. 10.1677/jme.1.01909.View Article
- Sinitskaya N, Gourmelen S, Schuster-Klein C, Guardiola-lemaitre B, Pévet P, Challet E: Increasing the fat-to-carbohydrate ratio in a high-fat diet prevents the development of obesity but not a prediabetic state in rats. Clinical Science. 2007, 113: 417-425. 10.1042/CS20070182.View ArticlePubMed
- King DE, Egan BM, Geesey ME: Relation of dietary fat and fiber to elevation of C-reactive protein. Am J Cardiol. 2003, 92: 1335-1339. 10.1016/j.amjcard.2003.08.020.View ArticlePubMed
- Storlien LH, Baur LA, Kriketos AD, Pan DA, Cooney GJ, Jenkins AB, Calvert GD, Campbell LV: Dietary fats and insulin action. Diabetologia. 1996, 39: 621-631. 10.1007/BF00418533.View ArticlePubMed
- Tannock LR, O'Brien KD, Knopp RH, Retzlaff B, Fish B, Wener MH, Kahn SE, Chait A: Cholesterol feeding increases C-reactive protein and serum amyloid A levels in lean insulin-sensitive subjects. Circulation. 2005, 111: 3058-3062. 10.1161/CIRCULATIONAHA.104.506188.View ArticlePubMed
- Due A, Toubro S, Stender S, Skov AR, Astrup A: The effect of diets high in protein or carbohydrate on inflammatory markers in overweight subjects. Diabetes Obesity Metabolism. 2005, 7: 223-229. 10.1111/j.1463-1326.2004.00426.x.View Article
- Garg A, Grundy SM, Koffler M: Effect of high carbohydrate intake on hyperglycemia, islet function, and plasma lipoproteins in NIDDM. Diabetes Care. 1992, 15: 1572-1579. 10.2337/diacare.15.11.1572.View ArticlePubMed
- Nappo F, Esposito K, Cioffi M, Giugliano G, Molinari AM, Paolisso G, Marfella R, Giugliano D: Postprandial endothelial activation in healthy subjects and in type 2 diabetic patients: role of fat and carbohydrate meals. J Am Coll Cardiol. 2002, 39: 1145-1150. 10.1016/S0735-1097(02)01741-2.View ArticlePubMed
- Wolever TMS: The Glycaemic Index A Physiological Classification of Dietary Carbohydrate. 2006, Oxfordshire, UK: CABIView Article
- Jönsson T, Granfeldt Y, Ahrén B, Branell U-C, Pålsson G, Hansson A, Söderström M, Lindeberg S: Beneficial effects of a Paleolithic diet on cardiovascular risk factors in type 2 diabetes: a randomized cross-over pilot study. Cardiovasc Diabetol. 2009, 8: 35-10.1186/1475-2840-8-35.PubMed CentralView ArticlePubMed
- Sabaté E: Adherence to long-term therapies: evidence for action. 2003, Geneva, Switzerland: World Health Organization
- Afman L, Müller M: Nutrigenomics: from molecular nutrition to prevention of disease. J Am Diet Assoc. 2006, 106: 569-576. 10.1016/j.jada.2006.01.001.View ArticlePubMed
- Müller M, Kersten S: Nutrigenomics: goals and strategies. Nature Reviews Genetics. 2003, 4: 315-322. 10.1038/nrg1047.View ArticlePubMed
- Koopmans SJ, Mroz Z, Dekker R, Corbijn H, Ackermans M, Sauerwein H: Association of insulin resistance with hyperglycemia in streptozotocin-diabetic pigs. Effects of metformin at isoenergetic feeding in a type 2-like diabetic pig model. Metabolism. 2006, 55: 960-971. 10.1016/j.metabol.2006.03.004.View ArticlePubMed
- Miller ER, Ullrey DE: The pig as a model for human nutrition. Ann Rev Nutr. 1987, 7: 361-382. 10.1146/annurev.nu.07.070187.002045.View Article
- Moughan PJ, Cranwell PD, Darragh AJ, Rowan AM: The domestic pig as a model animal for studying digestion in humans. Sixth International Symposium on digestive physiology in pigs II. 1994, 389-396.
- Dixon JL, Stoops JD, Parker JL, Laughlin MH, Weisman GA, Sturek M: Dyslipidemia and vascular dysfunction in diabetic pigs fed an atherogenic diet. Arterioscler Thromb Vasc Biol. 1999, 19: 2981-2992. 10.1161/01.ATV.19.12.2981.View ArticlePubMed
- Fricker J: The pig: a new model of diabetic atherosclerosis. DDT. 2001, 6: 921-922.View ArticlePubMed
- Gerrity RG, Natarajan R, Nadler JL, Kimsey T: Diabetes-induced accelerated atherosclerosis in swine. Diabetes. 2001, 50: 1654-1665. 10.2337/diabetes.50.7.1654.View ArticlePubMed
- Zhang L, Zalewski A, Liu Y, Mazurek T, Cowan S, Martin JL, Hofmann SM, Vlassara H, Shi Y: Diabetes-induced oxidative stress and low-grade inflammation in porcine coronary arteries. Circulation. 2003, 108: 472-478. 10.1161/01.CIR.0000080378.96063.23.View ArticlePubMed
- Festa A, D'Agostino R, Howard G, Tracy RP, Haffner SM: Chronic subclinical inflammation as part of the insulin resistance syndrome. Circulation. 2000, 102: 42-47.View ArticlePubMed
- Bays H, Mandarino L, DeFronzo RA: Role of the adipocyte, free fatty acids, and ectopic fat in pathogenesis of type 2 diabetes mellitus: peroxisomal proliferator-activated receptor agonists provide a rational therapeutic approach. J Clin Endo Metab. 2004, 89: 463-478. 10.1210/jc.2003-030723.View Article
- Kilkenny C, Browne WJ, Cuthill IC, Emerson M, Altman DG: Improving bioscience research reporting: the ARRIVE guidelines for reporting animal research. PLoS Biol. 2010, 8 (6): e1000412..PubMed CentralView ArticlePubMed
- Koopmans SJ, Van der Meulen J, Dekker R, Corbijn H, Mroz Z: Diurnal variation in insulin-stimulated systemic glucose and amino acid utilization in pigs fed with identical meals at 12-hour intervals. Horm Metab Res. 2006, 38: 607-613. 10.1055/s-2006-951306.View ArticlePubMed
- Koopmans SJ, Mroz Z, Dekker R, Corbijn H, Wijdenes J, Van der Crabben S, Ackermans M, Sauerwein HP: Insulin-stimulated net utilization of plasma glucose and amino acids in growing pigs. Progress in research on energy and protein metabolism. Edited by: Souffrant WB, and Metges CC. 2003, 109: 197-200.
- Eggstein M, Kreuz FH: Eine neue bestimmung der Neutralfette im Blutserum und Gewebe. Klin Wochenschr. 1966, 44: 262-267. 10.1007/BF01747716.View ArticlePubMed
- Stary HC, Chandler AB, Glagov S, Guyton JR, Insull W, Rosenfeld ME, Schaffer SA, Schwartz CJ, Wagner WD, Wissler RW: A definition of initial, fatty streak, and intermediate lesions of atherosclerosis. Circulation. 1994, 89: 2462-78.View ArticlePubMed
- Payne RW, Lane PW, Ainsley AE: Genstat 5 Reference Manual. 1987, Oxford, UK: Oxford University Press
- Opara EC, Garfinkel M, Hubbard VS, Burch WM, Akwari OE: Effect of fatty acids on insulin release: role of chain length and degree of unsaturation. Am J Physiol. 1994, 266: E635-E639.PubMed
- Allick G, Bisschop PH, Ackermans MT, Endert E, Meijer AJ, Kuipers F, Sauerwein HP, Romijn JA: A low-carbohydrate/high-fat diet improves glucoregulation in type 2 diabetes mellitus by reducing postabsorptive glycogenolysis. J Clin Endocrinol Metab. 2004, 89: 6193-6197. 10.1210/jc.2004-1041.View ArticlePubMed
- Pan DA, Lillioja S, Kriketos AD, Milner MR, Baur LA, Bogardus C, Jenkins AB, Storlien LH: Skeletal muscle triglyceride levels are inversely related to insulin action. Diabetes. 1997, 46: 983-988. 10.2337/diabetes.46.6.983.View ArticlePubMed
- Ciubotaru I, Lee YS, Wander RC: Dietary fish oil decreases C-reactive protein, interleukin-6, and triacylglycerol to HDL-cholesterol ratio in postmenopausal women on HRT. J Nutr Biochem. 2003, 14: 513-521. 10.1016/S0955-2863(03)00101-3.View ArticlePubMed
- Phinney SD: Fatty acids, inflammation, and the metabolic syndrome. Am J Clin Nutr. 2005, 82: 1178-1184.
- Turk JR, Carroll JA, Laughlin MH, Thomas TR, Casati J, Bowles DK, Sturek M: C-reactive protein correlates with macrophage accumulation in coronary arteries of hypercholesterolemic pigs. J Appl Physiol. 2003, 95: 1301-1304.View ArticlePubMed
- Verhamme P, Quarck R, Hao H, Knaapen M, Dymarkowski S, Bernar H, Van Cleemput J, Janssens S, Vermylen J, Gabbiani G, Kockx M, Holvoet P: Dietary cholesterol withdrawal reduces vascular inflammation and induces coronary plaque stabilization in miniature pigs. Cardiovasc Res. 2002, 56: 135-144. 10.1016/S0008-6363(02)00515-1.View ArticlePubMed
- Pepys MB, Hirschfield GM, Tennent GA, Gallimore R, Kahan MC, Bellotti V, Hawkins PN, Myers RM, Smith MD, Polara A, Cobb AJA, Ley SV, Aquilina A, Robinson CV, Sharif I, Gray GA, Sabin CA, Jenvey MC, Kolstoe SE, Thompson D, Wood SP: Targeting C-reactive protein for the treatment of cardiovascular disease. Nature. 2006, 440: 1217-1221. 10.1038/nature04672.View ArticlePubMed
- Bisoendial RJ, Kastelein JJP, Stroes ESG: C-reactive protein and atherogenesis: From fatty streak to clinical event. Atherosclerosis. 2007, 195: e10-e18. 10.1016/j.atherosclerosis.2007.04.053.View ArticlePubMed
- Koenig W, Khuseyinova N: Biomarkers of atherosclerotic plaque instability and rupture. Arterioscler Thromb Vasc Biol. 2007, 27: 15-26. 10.1161/01.ATV.0000251503.35795.4f.View ArticlePubMed
- Li SH, Szmitko PE, Weisel RD, Wang CH, Fedak PWM, Li RK, Mickle DAG, Verma S: C-reactive protein upregulates complement-inhibitory factors in endothelial cells. Circulation. 2004, 109: 833-6. 10.1161/01.CIR.0000117087.27524.0E.View ArticlePubMed
- Duplus E, Glorian M, Forest C: Fatty acid regulation of gene transcription. J Biol Chem. 2000, 275: 30749-30752.View ArticlePubMed
- Ferre P: The biology of peroxisome proliferator-activated receptors: relationship with lipid metabolism and insulin sensitivity. Diabetes. 2004, 53: S43-50. 10.2337/diabetes.53.2007.S43.View ArticlePubMed
- Ishibashi M, Egashira K, Hiasa K, Inoue S, Ni W, Zhao Q, Usui M, Kitamoto S, Ichiki T, Takeshita A: Antiinflammatory and antiarteriosclerotic effects of pioglitazone. Hypertension. 2002, 40: 687-693. 10.1161/01.HYP.0000036396.64769.C2.View ArticlePubMed
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.